← Back to Search

NAVAH for Cancer

N/A

Waitlist Available

Led By Shearwood McClelland III, MD

Research Sponsored by Case Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately following radiotherapy treatment

Awards & highlights

Study Summary

This trial found that African-Americans have less access to optimal cancer care, resulting in higher death rates & shorter survival times.

Who is the study for?

This trial is specifically for African-American adults over 18 with confirmed breast or prostate cancer. Participants must be able to give informed consent and understand the study requirements. It's not open to individuals who are not of African-American ethnicity or those without a confirmed diagnosis.Check my eligibility

What is being tested?

The NAVAH intervention is being tested to see if it can improve the completion rates of radiation therapy among African-American patients with breast or prostate cancer, addressing disparities in access to optimal cancer care.See study design

What are the potential side effects?

Since NAVAH is an intervention aimed at improving treatment adherence rather than a drug, traditional side effects are not applicable. However, there may be indirect effects related to changes in how radiation therapy is managed.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately following radiotherapy treatment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately following radiotherapy treatment

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately following radiotherapy treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Evaluation of barriers to navigator access

Secondary outcome measures

Assess the impact of patient navigation on patient access to radiation oncology care

Minority financial toxicity differences

Trial Design

1Treatment groups

Experimental Treatment

Group I: Navigator-Assisted Hypofractionation (NAVAH)Experimental Treatment1 Intervention

This pilot cohort study is designed as follows: Navigator discussion with patients prior to the start of radiation therapy simulation (15-30 minutes). Navigator administration of survey with patients after completion of radiation therapy simulation but before the start of radiation therapy (30-45 minutes) Navigator administration of post-treatment survey and financial toxicity survey instrument after the completion of radiation therapy (60 minutes).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University Hospitals Cleveland Medical CenterOTHER

318 Previous Clinical Trials

339,885 Total Patients Enrolled

3 Trials studying Prostate Cancer

528 Patients Enrolled for Prostate Cancer

Gilead SciencesIndustry Sponsor

1,084 Previous Clinical Trials

848,062 Total Patients Enrolled

1 Trials studying Prostate Cancer

55 Patients Enrolled for Prostate Cancer

Case Comprehensive Cancer CenterLead Sponsor

453 Previous Clinical Trials

31,690 Total Patients Enrolled

31 Trials studying Prostate Cancer

2,913 Patients Enrolled for Prostate Cancer

Media Library

$Navigator-Assisted Hypofractionation (NAVAH) Clinical Trial Eligibility Overview. Trial Name: NCT05978232 — N/A$

$Prostate Cancer Research Study Groups: Navigator-Assisted Hypofractionation (NAVAH)$

$Prostate Cancer Clinical Trial 2023: Navigator-Assisted Hypofractionation (NAVAH) Highlights & Side Effects. Trial Name: NCT05978232 — N/A$

$Navigator-Assisted Hypofractionation (NAVAH) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05978232 — N/A$

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities for individuals to join this research experiment?

"Data hosted on clinicaltrials.gov confirms that this trial, initially posted December 1st 2023 and last edited July 28th 2023, is not currently accepting new participants. However, there are 2,716 other trials actively searching for patients to enrol right now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

NAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer Patients

2024. "NAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05978232.